Page last updated: 2024-12-08

(s-dinitrophenyl)-6-mercaptopurine riboside triphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

The compound you're describing, **(s-dinitrophenyl)-6-mercaptopurine riboside triphosphate**, is a complex molecule with two main parts:

* **(s-dinitrophenyl):** This part is a chemical modification with a dinitrophenyl group attached to the molecule. Dinitrophenyl groups are known to be bulky and can interfere with interactions with other molecules.
* **6-mercaptopurine riboside triphosphate:** This is the core structure, which is a nucleotide. It consists of 6-mercaptopurine, a purine analog that can interfere with DNA synthesis and cell division, attached to a ribose sugar and three phosphate groups.

**This specific compound is likely designed for research purposes, as it combines the following properties:**

* **Inhibition of DNA synthesis:** The 6-mercaptopurine part can act as an inhibitor of DNA synthesis by interfering with the enzymatic activity of enzymes involved in DNA replication.
* **Modification for specific targeting:** The dinitrophenyl group might be used to introduce a specific binding property to the molecule, potentially allowing it to bind to a particular target within the cell. This could be useful for studying the mechanisms of DNA synthesis, targeting specific pathways, or developing novel therapeutic agents.

**Why is it important for research?**

The compound can be used in various research fields:

* **Cancer research:** By interfering with DNA synthesis, it could have potential as an anticancer agent.
* **Immunology:** It could be used to study the role of DNA synthesis in immune responses.
* **Drug development:** This compound could be a starting point for developing novel drugs that target specific pathways or enzymes involved in DNA replication.

**However, without further context, it's difficult to determine the exact application of this compound in research.** Its significance depends on its specific properties and the research questions being addressed.

To get a more accurate understanding of its importance, you would need to consult the specific research paper or project where it is mentioned.

(S-dinitrophenyl)-6-mercaptopurine riboside triphosphate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID193860
MeSH IDM0110554

Synonyms (7)

Synonym
dmrt
(s-dinitrophenyl)-6-mercaptopurine riboside triphosphate
51640-19-8
[9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-methyloxolan-2-yl]-2-(2,4-dinitrophenyl)sulfanylpurin-6-yl] [hydroxy(phosphonooxy)phosphoryl] hydrogen phosphate
9h-purine, 6-((2,4-dinitrophenyl)thio)-9-(5-o-(hydroxy((hydroxy(phosphonooxy)phosphinyl)oxy)phosphinyl)-beta-d-ribofuranosyl)-
9-(5-deoxypentofuranosyl)-2-[(2,4-dinitrophenyl)sulfanyl]-6-[(hydroxy{[hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl)oxy]-9h-purine
DTXSID20965945
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.87 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]